Skip to content
Open access

Machine Learning approaches for the detection of disease-causing variants in whole-genome data need to address the expression of functional genes

Aug 2026 · PLoS ONE · Vol 21 · 0 citations · 120 references
Medicine

TL;DR

A benchmark is constructed that includes real data and synthetic data with known generating mechanisms and various dataset sizes and levels of noise, and shows that it is necessary to take into account the expression of functional genes in order to successfully predict disease.

Abstract

Gene-dosage combinations have been recognised as leading factors of disease. Given that those combinations may include dozens of genes, it is hypothesised that machine learning (ML) approaches may be useful in the classification of cases and controls and the identification of causative genes. We aimed to assess the validity of this hypothesis. Here, we have constructed a benchmark that includes real data (with ground truth knowledge) and synthetic data with known generating mechanisms and various dataset sizes and levels of noise. We trained standard statistical learning/ ML models on these datasets to classify disease phenotype. We present an analysis of how model performance varies across different synthetic genetic scenarios, and how it is impacted by dataset size. The logistic regression model was found to be the most reliable at causative gene identification across the synthetic datasets, despite not always performing the best in terms of classification performance and, in some cases, having a relatively low ROC AUC score. When our training attempts on the UK Biobank datasets failed, we performed an analysis into model performance vs dataset richness. Our results show that it is necessary to take into account the expression of functional genes in order to successfully predict disease.

Read PDF

Similar papers

Open access Aug 2026

Deep DNA and protein level feature integration for robust clinical variant interpretation using probabilistic gradient boosting

A probabilistic gradient boosting model on variant pathogenicity prediction that applies biological characteristics at both level of DNA and protein levels while also scaling the level of uncertainty in clinical decision making is presented.

Karthik V, S. Prejesh, Sumedh Deepak Kudale et al. · 0 citations
Review Open access Jul 2026

Exploring the use of machine and deep learning in genome-wide association studies: a comprehensive review

This review describes the main characteristics and limitations of standard statistical approaches for GWAS, the main uses of AI methods in computational genomics, and recent attempts to leverage AI strategies in GWAS and presents 30 methods designed to leverage AI in GWAS.

S. D’Antona, Mawada Elmagboul Abdalla Abakar, Daniele Ramazzotti et al. · 0 citations
Review Open access Aug 2026

A machine learning framework for predictive interpretation of variants of uncertain significance in hereditary cancer

This reproducible pipeline provides a clinically grounded computational approach to VUS triaging in precision oncology, with external validation supporting its generalizability to independent hereditary cancer gene datasets.

Nayeema Nizamuddin, Soham Biswas, Akshaykumar Zawar et al. · 0 citations
#explainable ai Open access Aug 2026

aiDIVA – hybrid AI for rare disease diagnostics using evidence-based, machine learning and language models

aiDIVA is presented, an ensemble-AI combining statistical and machine learning models trained on genomic and phenotypic data to identify causal variants among tens of thousands per patient, and applies a random forest model to classify pathogenicity and generates evidence-based scores for dominant and recessive disease...

D. Boceck, L. Laugwitz, M. Sturm et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.